Durgam Suresh K. 4
4 · Intra-Cellular Therapies, Inc. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
Durgam Suresh K.
EVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-03-10$131.24/sh−3,116$408,944→ 42,913 total - Exercise/Conversion
Restricted Stock Units
2025-03-10−7,345→ 0 total→ Common Stock (7,345 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-06−13,133→ 13,133 total→ Common Stock (13,133 underlying) - Exercise/Conversion
Common Stock
2025-03-06+13,133→ 44,256 total - Exercise/Conversion
Common Stock
2025-03-10+7,345→ 46,029 total - Tax Payment
Common Stock
2025-03-06$131.19/sh−5,572$730,991→ 38,684 total
Footnotes (5)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units and does not represent a sale by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F4]On March 6, 2023, the reporting person was granted 39,398 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
- [F5]On March 10, 2022, the reporting person was granted 22,034 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.